[SYRS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
05-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -15.73%
YoY- -33.57%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 6,276 5,467 7,802 5,697 5,162 4,827 5,699 6.65%
PBT -34,481 -25,146 -23,813 -26,027 -22,490 -14,228 -30,130 9.43%
Tax 712 -1,507 986 984 969 967 1,417 -36.87%
NP -35,193 -23,639 -23,813 -26,027 -22,490 -14,228 -30,130 10.94%
Tax Rate - - - - - - - -
Total Cost 41,469 29,106 31,615 31,724 27,652 19,055 35,829 10.26%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -560.76 -432.39 -305.22 -456.85 -435.68 -294.76 -528.69 4.01%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -5.51 -3.75 -3.78 -4.14 -3.60 -2.32 -4.91 8.01%
EPS Diluted -5.51 -3.75 -3.78 -4.14 -3.58 -2.32 -4.91 8.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.